Federal opportunity · Award Notice
AwardedLevalbuterol HCL Solution
SPE2D221R0116 · Dept of Defense · SAM.gov
Awarded to Teva Pharmaceuticals USA, Inc. Parsippany NJ 07054 USA · $5,687,207 · Aug 31, 2022
Who won it
- Awardee
- Teva Pharmaceuticals USA, Inc. Parsippany NJ 07054 USA
- Amount
- $5,687,207
- Award date
- Aug 31, 2022
- Contract number
- SPE2D222D0146
- Posted
- Aug 23, 2023
- NAICS code
- 325412 · Pharmaceutical Preparation Manufacturing
- Set-aside
- None
- Place of performance
- Cheshire
- Notice type
- Award Notice
- Solicitation number
- SPE2D221R0116
- Official notice
- View on SAM.gov →
Open opportunities in Pharmaceutical Preparation Manufacturing
- Methylphenidate ERDept of Defense · Due Nov 6, 2026 · Under a day left
- Medical Gas Cylinders, USP, Type I-DOT 3AA SteelDept of Defense · Due Nov 15, 2026 · 9 days left
- Epinephrine InjectorDept of Defense · Due Nov 16, 2026 · 10 days left
- Atropine Auto-InjectorDept of Defense · Due Nov 30, 2026 · 24 days left
- FentanylDept of Defense · No deadline listed
- Morphine Sulfate SolutionDept of Defense · No deadline listed
What the agency bought
P00003 SPE2D222D0146 Modification to incorporate Drug Supply Chain Security Act language into solication for subject contract. P00002 SPE2D222D0146 Modification to Invoke Option Year 1. P00001 SPE2D222D0146 Modification to incorporate clause FAR 52.204-27 Prohibituion on a ByteDance Covered Application (June 2023) Contract Award for Leavalbuterol HCL Solution SPE2D222D0146
From the official notice on SAM.gov.